| Literature DB >> 26996598 |
Jin Hur1, Jae-Il Choi1, Hwan Lee1, Pniel Nham1, Tae-Won Kim1, Cheong-Whan Chae1, Ji-Yeon Yun1, Jin-A Kang1, Jeehoon Kang2, Sang Eun Lee2, Chang-Hwan Yoon3, Kyungjin Boo4, Seokjin Ham5, Tae-Young Roh5, Jong Kwan Jun6, Ho Lee7, Sung Hee Baek8, Hyo-Soo Kim9.
Abstract
Hematopoiesis is regulated by crosstalk between long-term repopulating hematopoietic stem cells (LT-HSCs) and supporting niche cells in the bone marrow (BM). Here, we examine the role of CD82/KAI1 in niche-mediated LT-HSC maintenance. We found that CD82/KAI1 is expressed predominantly on LT-HSCs and rarely on other hematopoietic stem-progenitor cells (HSPCs). In Cd82(-/-) mice, LT-HSCs were selectively lost as they exited from quiescence and differentiated. Mechanistically, CD82-based TGF-β1/Smad3 signaling leads to induction of CDK inhibitors and cell-cycle inhibition. The CD82 binding partner DARC/CD234 is expressed on macrophages and stabilizes CD82 on LT-HSCs, promoting their quiescence. When DARC(+) BM macrophages were ablated, the level of surface CD82 on LT-HSCs decreased, leading to cell-cycle entry, proliferation, and differentiation. A similar interaction appears to be relevant for human HSPCs. Thus, CD82 is a functional surface marker of LT-HSCs that maintains quiescence through interaction with DARC-expressing macrophages in the BM stem cell niche.Entities:
Keywords: CD82/KAI1; DARC/CD234; LT-HSCs; bone marrow; macrophage; quiescence; stem cell niche; tetraspanin
Mesh:
Substances:
Year: 2016 PMID: 26996598 DOI: 10.1016/j.stem.2016.01.013
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 25.269